Mather Group
ABBV icon

Mather Group’s AbbVie ABBV Stock Holding History

Mather Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.39M Buy
35,883
+1,893
+6% +$485K 0.08% 111
2026
Q2 		$8.55M Sell
33,990
-645
-2% -$139K 0.07% 117
2026
Q1 		$7.53M Sell
34,635
-355
-1% -$78.7K 0.08% 99
2025
Q4 		$7.99M Buy
34,990
+102
+0.3% +$23.2K 0.08% 92
2025
Q3 		$8.08M Buy
34,888
+1,357
+4% +$276K 0.08% 91
2025
Q2 		$6.22M Buy
33,531
+3,153
+10% +$586K 0.07% 105
2025
Q1 		$6.36M Buy
30,378
+644
+2% +$125K 0.07% 102
2024
Q4 		$5.28M Buy
29,734
+950
+3% +$175K 0.07% 108
2024
Q3 		$5.68M Sell
28,784
-32,701
-53% -$6.1M 0.07% 107
2024
Q2 		$11.2M Buy
61,485
+34,287
+126% +$5.68M 0.14% 77
2024
Q1 		$4.21M Sell
27,198
-12,300
-31% -$2.12M 0.07% 104
2023
Q4 		$6.12M Buy
39,498
+1,787
+5% +$261K 0.1% 84
2023
Q3 		$5.62M Buy
37,711
+2,036
+6% +$299K 0.1% 81
2023
Q2 		$4.81M Buy
35,675
+857
+2% +$126K 0.08% 99
2023
Q1 		$5.55M Buy
34,818
+8,355
+32% +$1.28M 0.1% 82
2022
Q4 		$4.28M Sell
26,463
-298
-1% -$45.7K 0.08% 90
2022
Q3 		$3.59M Buy
26,761
+3,356
+14% +$482K 0.08% 91
2022
Q2 		$3.58M Buy
23,405
+410
+2% +$62.6K 0.08% 88
2022
Q1 		$3.73M Buy
+22,995
New +$3.34M 0.07% 83
2020
Q4 		– Sell
-18,206
Closed -$1.6M – 250
2020
Q3 		$1.6M Buy
18,206
+641
+4% +$60.3K 0.06% 68
2020
Q2 		$1.72M Buy
+17,565
New +$1.55M 0.08% 64

Other funds holding ABBV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Mather Group's ABBV Position: Q3 2026 in Review

Mather Group increased its AbbVie (ABBV) stake by 5.6% in Q3 2026, buying an estimated $485K and bringing the position to 35,883 shares worth $9.39M. The position accounts for 0.08% of the portfolio, ranked #111.

Mather Group first reported a position in ABBV in Q2 2020 and has held it in 21 quarters since. The position peaked at $11.2M in Q2 2024. 921 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Mather Group held 35,883 shares of AbbVie worth $9.39M as of Q3 2026.
  • Mather Group bought 1,893 AbbVie shares in Q3 2026, an estimated $485K.
  • AbbVie made up 0.08% of Mather Group's portfolio in Q3 2026, its #111 holding.
  • Mather Group first reported a position in AbbVie in Q2 2020 and has held it in 21 quarters since.
  • Mather Group's AbbVie position peaked at $11.2M in Q2 2024.
  • 921 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.